Immunoprecise Antibodies Ltd Free Cash Flow Generation Index
Immunoprecise Antibodies Ltd free cash flow generation index. Immunoprecise Antibodies Ltd (IPA) has a Free Cash Flow Generation Index of -0.62x as of October 2020. Free cash flow of $-274.98K represents -1% of operating cash flow ($440.23K).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Immunoprecise Antibodies Ltd (2016–2016)
Free cash flow generation index of Immunoprecise Antibodies Ltd from 2016 to 2016. Historical FCF Generation Index trend for Immunoprecise Antibodies Ltd across 1 annual periods. See Immunoprecise Antibodies Ltd (IPA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Immunoprecise Antibodies Ltd Free Cash Flow Generation Index by Year (2016–2016)
Immunoprecise Antibodies Ltd free cash flow generation index by year from 2016 to 2016. Year-by-year Free Cash Flow Generation Index for Immunoprecise Antibodies Ltd. For the full cash flow conversion analysis, see IPA cash generation efficiency.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.94x | $266.61K | $284.09K | $17.48K | — |